Literature DB >> 12797539

Correlates of IL-10 and IL-12 concentrations in cervical secretions.

Patti E Gravitt1, Allan Hildesheim, Rolando Herrero, Mark Schiffman, Mark E Sherman, M Concepcion Bratti, Ana C Rodriguez, Lidia A Morera, Fernando Cardenas, Frederick P Bowman, Keerti V Shah, Peggy A Crowley-Nowick.   

Abstract

Interindividual variations in host immune responses to HPV infection are thought to be important determinants of viral persistence and progression to cervical intraepithelial neoplasia and cancer. However, few studies have measured local immune markers at the site of infection (e.g., the cervical mucosa). We sought to determine biologic correlates of IL-10 and IL-12 concentrations in cervical secretions. Cervical secretions were passively collected using a WeckCel sponge from 247 women participating in a natural history study of human papillomavirus infection as part of an immunologic ancillary study. IL-10 and IL-12 concentrations were determined using standard ELISA assays. In general, IL-10 and IL-12 levels were significantly intercorrelated (Pearson's correlation coefficient = 0.6) but had somewhat different determinants. Significant increases (P < 0.05) in IL-10 concentrations were observed for nonovulatory phases of the menstrual cycle, postmenopausal status, recent use of oral contraceptives (OC), low secretion volume, macrolevels of heme contamination, and high vaginal pH. Increasing IL-10 levels were also observed among smokers, women with increasing numbers of lifetime sex partners, and women who report having less frequent sex (less than once per week), however, these results were not statistically significant. Significantly higher IL-12 concentrations were observed among recent OC users, women with low secretion volume, and women with a high vaginal pH. There was a non-statistically significant observation of increasing IL-12 levels among nonsmokers, women with increasing numbers of lifetime and recent pregnancies, and increasing levels of heme contamination. We failed to observe a significant association between HPV and IL-10 or IL-12 levels in this crosssectional sample. Future analyses of cervical cytokine levels and HPV infection should control for the inherent variation of local cytokine levels due to hormonal influences, hemoglobin contamination, pH, and cervical secretion volume differences.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12797539     DOI: 10.1023/a:1023305827971

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

1.  Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.

Authors:  P C Maciag; N F Schlecht; P S Souza; E L Franco; L L Villa; M L Petzl-Erler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-11       Impact factor: 4.254

2.  Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.

Authors:  K L Liaw; A G Glass; M M Manos; C E Greer; D R Scott; M Sherman; R D Burk; R J Kurman; S Wacholder; B B Rush; D M Cadell; P Lawler; D Tabor; M Schiffman
Journal:  J Natl Cancer Inst       Date:  1999-06-02       Impact factor: 13.506

3.  Cytokine and immunoglobulin concentrations in cervical secretions: reproducibility of the Weck-cel collection instrument and correlates of immune measures.

Authors:  A Hildesheim; L M McShane; M Schiffman; M C Bratti; A C Rodriguez; R Herrero; L A Morera; F Cardenas; L Saxon; F P Bowman; P A Crowley-Nowick
Journal:  J Immunol Methods       Date:  1999-05-27       Impact factor: 2.303

4.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes.

Authors:  S B Wilson; S C Kent; H F Horton; A A Hill; P L Bollyky; D A Hafler; J L Strominger; M C Byrne
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

6.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

Authors:  D Solomon; M Schiffman; R Tarone
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

7.  Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.

Authors:  E L Franco; L L Villa; J P Sobrinho; J M Prado; M C Rousseau; M Désy; T E Rohan
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

8.  Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.

Authors:  A Hildesheim; M Schiffman; D R Scott; D Marti; T Kissner; M E Sherman; A G Glass; M M Manos; A T Lorincz; R J Kurman; J Buckland; B B Rush; M Carrington
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-11       Impact factor: 4.254

9.  HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.

Authors:  R J Apple; H A Erlich; W Klitz; M M Manos; T M Becker; C M Wheeler
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

10.  Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women.

Authors:  J Cuzick; G Terry; L Ho; J Monaghan; A Lopes; P Clarkson; I Duncan
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

View more
  13 in total

1.  Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking.

Authors:  Mark E Scott; Yifei Ma; Sepideh Farhat; Stephen Shiboski; Anna-Barbara Moscicki
Journal:  J Clin Immunol       Date:  2006-05-16       Impact factor: 8.317

2.  Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women.

Authors:  Morgan A Marks; Raphael P Viscidi; Kathryn Chang; Michelle Silver; Anne Burke; Roslyn Howard; Patti E Gravitt
Journal:  Cytokine       Date:  2011-10-19       Impact factor: 3.861

Review 3.  The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes.

Authors:  Kerry Murphy; Caroline M Mitchell
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

4.  Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study.

Authors:  Jill Koshiol; Martha Sklavos; Nicolas Wentzensen; Troy Kemp; Mark Schiffman; S Terence Dunn; Sophia S Wang; Joan L Walker; Mahboobeh Safaeian; Rosemary E Zuna; Allan Hildesheim; Ruth M Pfeiffer; Ligia A Pinto
Journal:  Int J Cancer       Date:  2013-07-30       Impact factor: 7.396

5.  Comparison of normalization methods for measuring immune markers in cervical secretion specimens.

Authors:  Morgan A Marks; Yolanda Eby; Roslyn Howard; Patti E Gravitt
Journal:  J Immunol Methods       Date:  2012-06-04       Impact factor: 2.303

6.  Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle.

Authors:  Mahboobeh Safaeian; Roni T Falk; Ana Cecilia Rodriguez; Allan Hildesheim; Troy Kemp; Marcus Williams; Lidiana Morera; Manuel Barrantes; Rolando Herrero; Carolina Porras; Ligia Pinto
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

7.  Comparison of ophthalmic sponges for measurements of immune markers from cervical secretions.

Authors:  Philip E Castle; Ana-Cecilia Rodriguez; Frederick P Bowman; Rolando Herrero; Mark Schiffman; M Concepcion Bratti; Lidia Ana Morera; Danny Schust; Peggy Crowley-Nowick; Allan Hildesheim
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

8.  Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates.

Authors:  Jay A Lieberman; Anna-Barbara Moscicki; Jan L Sumerel; Yifei Ma; Mark E Scott
Journal:  Clin Vaccine Immunol       Date:  2007-10-31

9.  The SNP at -592 of human IL-10 gene is associated with serum IL-10 levels and increased risk for human papillomavirus cervical lesion development.

Authors:  Kirvis Torres-Poveda; Ana I Burguete-García; Miguel Cruz; Gabriela A Martínez-Nava; Margarita Bahena-Román; Esmeralda Ortíz-Flores; Abrahan Ramírez-González; Guillermina López-Estrada; Karina Delgado-Romero; Vicente Madrid-Marina
Journal:  Infect Agent Cancer       Date:  2012-11-14       Impact factor: 2.965

10.  The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma.

Authors:  Jimmy T Efird; Amanda E Toland; C Suzanne Lea; Christopher J Phillips
Journal:  Clin Med Insights Oncol       Date:  2011-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.